Executives On The Move: New Choices For Finance Spots At Merz Aesthetics, Spruce Biosciences And Lodo Therapeutics
Executive Summary
New CFOs are announced at three companies: MerzPharma Group’s Merz Aesthetics; Spruce Biosciences, a firm focusing on treatments for rare endocrine disorders; and Lodo Therapeutics, which is developing novel therapeutics for undruggable targets.